Federal Circuit Review - Volume 3 | Issue 7 July 2013


In This Issue:

• Isolated DNA not Patent Eligible

• Appeals Before Damages and Willfulness Determination OK

• Reverse Payment Settlement Agreements May be Invalid

- Excerpt from Isolated DNA not Patent Eligible:

In Association For Molecular Pathology v. Myriad Genetics, Inc., No. 12-398, the Supreme Court affirmed in part and reversed in part the Federal Circuit’s opinion which, on remand, had found both isolated DNA and cDNA patent eligible.

Respondent Myriad Genetics, Inc. (Myriad) obtained several patents after discovering the precise location and sequence of the BRCA1 and BRCA2 genes. Petitioners filed suit seeking a declaration that Myriad’s patents were invalid under 35 U.S.C. §101. The district court granted summary judgment to Petitioners, concluding that Myriad’s claims were invalid because they covered products of nature. The Federal Circuit initially reversed, but on remand in light of Mayo Collaborate Services v. Prometheus Laboratories, Inc., it ultimately found both isolated DNA and cDNA patent eligible.

Please see full Review below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Knobbe Martens Olson & Bear LLP | Attorney Advertising

Written by:


Knobbe Martens Olson & Bear LLP on:

JD Supra Readers' Choice 2016 Awards
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.